nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AI and neurology: an ethical path to innovation
|
The Lancet Neurology, |
|
|
24 |
5 |
p. 371 |
artikel |
2 |
Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathy
|
Balendra, Rubika |
|
|
24 |
5 |
p. 456-470 |
artikel |
3 |
Biological effects of pathologies in Lewy body diseases: why timing matters
|
Matar, Elie |
|
|
24 |
5 |
p. 441-455 |
artikel |
4 |
Carotid revascularisation for carotid stenosis
|
Ho, Jan K |
|
|
24 |
5 |
p. 372-373 |
artikel |
5 |
CGRP blockade and cluster headache: another step forward
|
Leroux, Elizabeth |
|
|
24 |
5 |
p. 377-378 |
artikel |
6 |
Correction to Lancet Neurol 2024; 23: 1013–24
|
|
|
|
24 |
5 |
p. e8 |
artikel |
7 |
Correction to Lancet Neurol 2024; 23: 500–10
|
|
|
|
24 |
5 |
p. e8 |
artikel |
8 |
Correction to Lancet Neurol 2025; 24: 290
|
|
|
|
24 |
5 |
p. e8 |
artikel |
9 |
Fraud, arrogance, and tragedy: the case of Doctored
|
Hardy, John |
|
|
24 |
5 |
p. 387 |
artikel |
10 |
Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial
|
Tassorelli, Cristina |
|
|
24 |
5 |
p. 429-440 |
artikel |
11 |
Margaret Pericak-Vance: a force of nature in human genetics
|
Morgan, Jules |
|
|
24 |
5 |
p. 385 |
artikel |
12 |
Neurology cannot be embedded in non-communicable disease agendas
|
Leonardi, Matilde |
|
|
24 |
5 |
p. 383-384 |
artikel |
13 |
Neuropathic pain: which treatment for which patient?
|
Sommer, Claudia |
|
|
24 |
5 |
p. 375-376 |
artikel |
14 |
Neurorights in neurology
|
Yuste, Rafael |
|
|
24 |
5 |
p. 386 |
artikel |
15 |
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial
|
Donners, Simone J A |
|
|
24 |
5 |
p. 389-399 |
artikel |
16 |
Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis
|
Soliman, Nadia |
|
|
24 |
5 |
p. 413-428 |
artikel |
17 |
Prioritising faster, individualised rescue treatment in status epilepticus
|
Vargas, Nathalia Penagos |
|
|
24 |
5 |
p. 382 |
artikel |
18 |
Prioritising faster, individualised rescue treatment in status epilepticus – Authors' reply
|
Gettings, Jennifer V |
|
|
24 |
5 |
p. 382-383 |
artikel |
19 |
Rehabilitation drives post-stroke motor recovery
|
Kimberley, Teresa J |
|
|
24 |
5 |
p. 373-375 |
artikel |
20 |
Roberta Messina
|
|
|
|
24 |
5 |
p. 386 |
artikel |
21 |
Safety and efficacy of transcranial direct current stimulation in addition to constraint-induced movement therapy for post-stroke motor recovery (TRANSPORT2): a phase 2, multicentre, randomised, sham-controlled triple-blind trial
|
Schlaug, Gottfried |
|
|
24 |
5 |
p. 400-412 |
artikel |
22 |
Temporal and biological heterogeneity in Lewy body disease
|
Lemstra, Afina W |
|
|
24 |
5 |
p. 378-379 |
artikel |
23 |
The four most common genetic subtypes of amyotrophic lateral sclerosis: state of the art and future directions
|
Shaw, Pamela |
|
|
24 |
5 |
p. 380-381 |
artikel |
24 |
Would you want to know if you had Alzheimer's disease?
|
Ranscombe, Peter |
|
|
24 |
5 |
p. 388 |
artikel |